CD19 and non-Hodgkin lymphoma: Currently, only a few scattered papers have reported changes in the cellular kinetics of CD19 CAR T cells in adults with NHL (9, 24), and no article has reported the pharmacokinetics of dual-target CAR T cells; thus, the cellular kinetics of CAR T cells after an infusion in patients with lymphoma remain poorly understood.